Summary: The brand new Biograph mCT Flow PET/CT scanner that Siemens unveiled at ASTRO also works in conjunction with Varian's RPM system.
September 25, 2013 - Varian Medical Systems and Siemens Healthcare featured several solutions for treating cancer with image-guided radiotherapy, radiosurgery, and brachytherapy at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting, held Sept. 22 to 25 at the Georgia World Congress Center in Atlanta.
As part of their EnVision Better Cancer Care global strategic partnership, the 2 companies showcased a new solution for respiratory gating and CT imaging solution interoperability is Siemens' CT scanner with Varian's Real-time Position Management™ (RPM) system. The brand new Biograph mCT Flow PET/CT scanner that Siemens unveiled at ASTRO also works in conjunction with Varian's RPM system, which enables clinicians to understand how a tumor moves during a treatment. This is designed to enable clinicians to compensate for tumor motion while planning and delivering radiotherapy treatments in the lung and other parts of the body that are subject to respiratory motion.
They also featured Varian Exchange, a new interface for connecting Varian's ARIA oncology information system with Siemens' ARTISTE medical linear accelerators.1
- Clinicians at The Ohio State University are now using Varian software to plan and manage radiotherapy treatments delivered on a Siemens medical linear accelerator. Varian Medical Systems and Siemens Healthcare have developed and deployed an interface that connects Varian's ARIA oncology information system with Siemens' Oncor and Primus accelerators and imaging systems.
Earlier this year, Varian and Siemens announced an interface that connected ARIA with Siemens' ONCOR and PRIMUS accelerators. The interface is designed to provide connectivity for a full range of Siemens treatment machines for use with ARIA.
Another solution on display was Siemens SOMATOM CT Sliding Gantry scanner with Varian brachytherapy technology to enable 3-D image-guided high-dose-rate (HDR) brachytherapy procedures within a single treatment room.
HDR brachytherapy involves delivering radiotherapy from inside the body by temporarily placing a tiny radioactive source directly into the tumor or other targeted area. Using a robotic device called an afterloader, clinicians place the radioactive source into positions through applicators that have been inserted into the area being treated.
1 Pending FDA clearance and not commercially available in the U.S. Due to regulatory reasons, future availability cannot be guaranteed.
For more information: www.varian.com, www.siemens.com, and and www.appliedradiology.com